Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
EventsCardiawave has secured the 2nd position among 50 exceptional participants for the prestigious John DeHann Foundation Award – May 15 – Paris Jun 8, 2023 © Cardiovascular News READ MORE
Scientific PublicationsSystematic brain magnetic resonance imaging and safety evaluation of non-invasive ultrasound therapy for patients with severe symptomatic aortic valve stenosis May 24, 2023 READ MORE
EventsCardiawave has been selected to participate to the Jon DeHaan Foundation Award Competition during EuroPCR Innovators’ Day – May 15 – Paris May 11, 2023 READ MORE
EventsCardiawave will participate in the 2nd edition of the HIFUture symposium – Apr. 21 – Lyon Apr 20, 2023 READ MORE
EventsCardiawave will be presenting at the combined ISTU/EUFUS Symposium – Apr. 18 – Lyon Apr 18, 2023 READ MORE
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
